Oncology

A recent study from the REACT initiative highlights a significant gap in fertility preservation discussions for early-onset cancer patients, with nearly half reporting that they were not informed about fertility options before beginning treatment.

A new study reveals that combining proton beam therapy with boron neutron capture reactions increases its cell-killing effect, with higher boron concentrations yielding stronger therapeutic results…

Restaging MRI is a powerful tool for predicting survival and organ preservation in rectal cancer patients after total neoadjuvant therapy…

A new phase 3 trial (INTERLACE) shows that adding induction chemotherapy to standard chemoradiotherapy improves both progression-free and overall survival in patients with locally advanced cervical cancer.

A new study reveals how the m6A epitranscriptomic modification and MYCN oncogene cooperate to maintain an undifferentiated state in neuroblastoma…

Researchers have developed a novel treatment for non-small cell lung cancer (NSCLC) that uses customised antisense oligonucleotides (ASOs) to selectively target drug-resistant EGFR mutations.

A recent trial found that three cycles of CEV chemotherapy are as effective as six in treating high-risk unilateral retinoblastoma after enucleation.

A recent study uncovers genetic vulnerabilities in glioblastoma stem cells, pinpointing subtype-specific dependencies that drive tumour growth.